Sinovac

China’s habit of disappearing and censoring critics is not the way to win trust in its vaccine industry.

How has China approached vaccine diplomacy in Southeast Asia?

The report from Caixin comes as the efficacy of homegrown vaccines from Sinopharm and Sinovac continue to be questioned.

In parts of densely-populated Java, the surge in coronavirus cases has pushed hospitals to full capacity.

Despite some concerns and criticisms abroad, most Chinese (and expats) are eager to roll up their sleeves for the jab.

China's vaccine makers are looking at ways to increase the efficiency of their shots.

Beijing's comments on “vaccine nationalism” hints at its desire to position itself as the vaccine supplier of first resort to the developing world.

With public trust in tatters, vaccine hesitancy has become a serious hurdle for the government’s pandemic strategy.

An in-depth look at where China's vaccines are going hints at the motivations behind the campaign.

The recent controversy over a dengue vaccine has complicated the Philippines’ COVID-19 vaccination program.

Despite cooperating on some aspects, China and Russia are also directly competing for the same vaccine markets - and the national prestige that comes with it.